ASX:SPL

Email Alerts for:
ASX:SPL

Starpharma Holdings (ASX:SPL) - Webinar Presentation

23 Sep 2023 - Dr Jackie Fairley - CEO - Starpharma Holdings (ASX:SPL) is a world leader in the development of dendrimer products for pharmaceutical, life science and other applicat…

The Christmas Star

20 Dec 2021 - Market analyst Regina Meani discusses Starpharma Holdings (ASX:SPL).

Starpharma (ASX:SPL) signs Viraleze distribution agreement

03 Dec 2021 - Starpharam (ASX:SPL) has signed an ongoing agreement for the distribution of the VIRALEZE antiviral nasal spray in Vietnam.

Tabcorp drops 4% on demerger news: ASX closed 0.1% higher

05 July 2021 - The Australian share market closed flat at 0.09% or 6.40 points higher at 7,315. Industrials was the best-performing sector jumped 4.9% while Information Technology …

Sydney Airport soars 30%, A2 Milk up 4.1%: ASX tracking 0.2% higher at noon

05 July 2021 - The Australian sharemarket has started the week on a positive note following a strong lead from Wall St trading 0.2 per cent or 10.9 points higher at 7,320 at noon.

Starpharma (ASX:SPL) receives hefty fines for alleged advertising of Viraleze

05 July 2021 - Starpharma (ASX:SPL) has received $93,240 worth of infringement notices from the Therapeutic Goods Administration.

Starpharma (ASX:SPL)'s nasal spray achieves 98% efficacy against COVID-19

01 June 2021 - Biopharmaceutical company Starpharma (ASX:SPL) claims the company’s nasal spray product is a highly efficacious means of protection from the UK variant of the corona…

Household wealth at 11-year highs: ASX closes 0.2% higher

25 Mar 2021 - The ASX pushed into the green from a flat start, faded in afternoon trade and surprised investors with a late jump to close 0.2% higher. Improvements were seen across…

Starpharma (ASX:SPL) signs distribution agreement with LloydsPharmacy in UK

25 Mar 2021 - Starpharma (ASX:SPL) signs agreement with LloydsPharmacy in the UK for the distribution of its VIRALEZE antiviral nasal spray.

Starpharma (ASX:SPL) reports DEP HER2-lutetium shows potent anticancer effect

16 Mar 2021 - Starpharma (ASX:SPL) says its second radiopharmaceutical candidate, DEP HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regressio…

Starpharma (ASX:SPL) receives EU approval for anti-COVID nasal spray

23 Feb 2021 - Pharmaceutical developer Starpharma (ASX:SPL) has received EU approval for the company’s antiviral nasal spray Viraleze.

Tourism's contribution to GDP fell to 2.5%: ASX closed 0.7% lower

10 Dec 2020 - The ASX failed to gain momentum today closing 0.7% lower. Shares in Fortescue Metals Group (ASX:FMG) did well today after yesterday reporting their first ore at Eliw…

Starpharma (ASX:SPL) report their Covid-19 nasal spray is almost ready for market

10 Dec 2020 - Starpharma (ASX:SPL) says their Covid-19 nasal spray Viraleze will soon be ready for market.

Unemployment rate increased to 7% in October: ASX now tracking 0.3% lower at noon

19Nov 2020 - The ASX now tracking 0.3% lower at noon. Shares in Bluescope Steel (ASX:BSL) and Virgin Money (ASX:VUK) both did well today. United Malt Group (ASX:UMG) shares are dow…

Retail sales have fallen 1.5% in September: ASX tracking 0.1% higher at noon

21 Oct 2020 - The ASX rose at the open and is now tracking 0.1% higher at noon. Shares in Orora (ASX:ORA) are up as they report their first quarter US earnings are doing well. Shar…

Financials defy recession odds: Aus shares close 0.8% higher

03 Sep 2020 - The Australian share market shot up at the open following strong performance levels on Wall Street, especially record highs on the Nasdaq and S&P 500. Australia has r…

Starpharma (ASX:SPL) awarded $1 million funding for Covid-19 spray

03 Sep 2020 - Starpharma (ASX:SPL) has been awarded $1 million in matched funding by the Australian Government’s Medical Research Future Fund (MRFF) Biomedical Translation Bridge (…

Starpharma (ASX:SPL) creates soluable version of their Covid treatment

01 Sep 2020 - Starpharma (ASX:SPL) today announced it has applied its novel DEP® drug delivery technology to create a long-acting, water soluble version of remdesivir.

ANZ (ASX:ANZ) announce Chairman: Aus shares close 0.2% higher

27 Aug 2020 - The Australian share market rose at the open closing 0.2 per cent up at the end of trade. ANZ (ASX:ANZ) announced Paul O’Sullivan will succeed David Gonski as the Gro…

Starpharma (ASX:SPL) see revenue rise 142%

27 Aug 2020 - Starpharma (ASX:SPL) report their revenue is up 142 per cent to $6.56 million.

Leading Index remains at recession levels: Aus shares close 0.8% higher

17 Jun 2020 - The Australian share market rose at the open closing 0.8 per cent up at the end of trade. The Index growth rate remains in deep negative territory with the growth rat…

Starpharma's (ASX:SPL) DEP lutetium effective in cancer: Aus shares 0.2% up at midday

17 Jun 2020 - The Australian share market opened higher this morning and is now trading 0.2 per cent higher at noon. Starpharma (ASX:SPL) has reported that its DEP lutetium candida…

Starpharma (ASX:SPL) launches VivaGel in Europe

16 Jun 2020 - Starpharma (ASX:SPL) today announced that VivaGel BV has been launched in Central and Eastern European region.

Australian lamb exports take-off for Abu Dhabi: ASX set for a fall

16 Apr 2020 - Wall Street saw a sell-off yesterday after economic data showed more companies were facing hard times due to the coronavirus pandemic. The ASX looks set to crash open…

Starpharma (ASX:SPL) see Okamoto licence Vivagel condoms in Asian countries

04 Mar 2020 - Starpharma (ASX:SPL) today announced that following the successful launch of the VivaGel antiviral condom by Okamoto Industries in Japan, they are now seeking to expa…